Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Kratom Korea"

09:04 EDT 24th April 2014 | BioPortfolio

Original Source: A Case Report of Inpatient Detoxification after Kratom (Mitragyna speciosa) Dependence.

Kratom (Mitragyna speciosa) has been used for medicinal and recreational purposes. It has reported analgesic, euphoric and antitussive effects via its action as an agonist at opioid receptors. It is illegal in many countries including Thailand, Malaysia, Myanmar, South Korea and Australia; however, it remains legal or uncontrolled in the UK and USA, where it is easily available over the Internet. We describe a case of kratom dependence in a 44-year-old man with a history of alcohol dependence and anxiety di...

Matching Channels


Matching News

Kratom Import Alert Clarifies FDA Deems The Botanical An Unsafe NDI

FDA cautioned manufacturers about kratom’s safety as a dietary ingredient in 2013, but industry stakeholders posited that the agency should clarify whether the botanical is a legitimate supplement i...

Dominion Diagnostics launches Kratom testing to address growing designer drug use trend

NORTH KINGSTOWN, R.I., Feb. 10, 2014 /PRNewswire/ -- Dominion Diagnostics, a leading national provider of drug testing, medication monitoring, and clinical support services, launched new testing...

Top 10 VC-backed startups in Korea: Kakao still dominates

Under The Radar, a prominent IT and startup-focused blog in Korea, recently published a top 10 list of venture backed enterprises in Korea. Not surprisingly, Kakao placed number one in...

Korea, Switzerland Ink MOU To Combine Talents In Pharma, Medical Devices

In a bid to bolster their respective health care industries, South Korea and Switzerland signed an MOU to cooperate on life sciences investments by combining Switzerland’s knowhow in precision machi...

Korea’s Health Ministry To Discontinue Controversial Pricing Policy

Amid strong opposition from within and outside Korea from pharma groups, Korea’s health ministry said it will discontinue its market-based actual transaction price system.

Korea’s Green Cross To Seek Regulatory Approval For Biobetter Of Shire’s Elaprase In Japan, China

Because of the limited number of Hunter syndrome patients worldwide, Green Cross is looking to expand sales of its biosimilar Hunterase from South Korea to Japan and China – BIO Korea 2012.

South Korea in rare offer of aid to North for foot-and-mouth outbreak

SEOUL (Reuters) - South Korea has offered North Korea help with an outbreak of foot-and-mouth disease in pigs, which would be the first government-level humanitarian help since 2010 and comes as ties...

No Good News For Pharma In Korea As Most Companies See Sales Decline

Foreign and domestic companies performed poorly during the first nine months in South Korea with no positive factors on the horizon.

Matching PubMed Articles

Contributions to the foliicolous lichens flora of South Korea.

South Korea is covered primarily by temperate vegetation; therefore, foliicolous lichens may not be expected to play an important role in its lichen flora. However, this study describes four foliicolo...

The Drug Resistance Profile of Mycobacterium abscessus Group Strains from Korea.

Bacteria of the Mycobacterium abscessus group are the second most common pathogens responsible for lung disease caused by nontuberculous mycobacteria in Korea. There is still a lack of studies investi...

Characteristics of Acromegaly in Korea with a Literature Review.

Acromegaly is a slowly progressive disease caused by excessive growth hormone (GH), which is related to a GH secreting pituitary tumor in most cases. Herein, we describe the epidemiology, clinical cha...

Vitamin D Status in Korea.

The majority of the vitamin D in our body is produced by cutaneous synthesis in response to sunlight. As more and more people live in cities and spend the bulk of their time indoors, it can be difficu...

The economic burden of epilepsy in Korea, 2010.

The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010.

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement